Inhibition of vasopressor responses by cadmium.
D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects* / Q000502:physiology; D002104:Cadmium / Q000494:pharmacology*; D004837:Epinephrine / Q000037:antagonists & inhibitors*; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D011817:Rabbits; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000037:antagonists & inhibitors*
D014662:Vasoconstrictor Agents; D002104:Cadmium; D000804:Angiotensin II; D009638:Norepinephrine; D004837:Epinephrine